Navigation Links
PDI Signs Agreement with HealthTrust for Surface Disinfection Products
Date:11/6/2012

ORANGEBURG, N.Y., Nov. 6, 2012 /PRNewswire/ -- PDI, provider of infection prevention education, clinical support and products, has been awarded a contract for surface disinfection from HealthTrust, effective November 1, 2012. The contract makes the full line of Sani-Cloth® Germicidal Disposable Wipes, designed to service all areas of the healthcare facility, available to HealthTrust members.

"This new agreement will afford PDI the opportunity to work with HealthTrust's diverse membership, aid them in reducing healthcare-associated infections and control associated costs," said Dan Marsh, executive vice president, PDI.

PDI Sani-Cloth Germicidal Disposable Wipes is the number one brand of surface disinfecting wipes in healthcare and includes Super Sani-Cloth®, Sani-Cloth® AF3, and Sani-Cloth® Bleach. The product portfolio offers a complete environmental hygiene solution for house-wide and situational use with the appropriate mix of aggressive clinically-relevant efficacy claims. Effective against 27 different microorganisms in two minutes, Super Sani-Cloth® is ideal for daily use in fast-paced environments. Sani-Cloth® AF3 is ideal for use around patients and staff as well as on sensitive equipment. It is alcohol and fragrance free and effective against 44 different microorganisms in three minutes. Sani-Cloth® Bleach is effective against 50 different microorganisms including 14 multidrug-resistant organisms, Norovirus and Clostridium difficile spores in four minutes and is designed to be used in high-risk areas.

The Sani-Cloth Environmental Hygiene System provides users with a broad range of intermediate-level surface disinfectants that address all surface disinfection needs. Equally important to the products are PDI's compliance tools, optional dispensing accessories, ongoing clinical support and comprehensive implementation training for staff.

About H
'/>"/>

SOURCE PDI
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
2. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
3. VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
4. Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC
5. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
6. H. D. Smith Signs Three Year Prime Vendor Agreement with PharmacyGPO Buying Group
7. Bacterin International Signs Its Third National GPO Contract with Novation
8. MusclePharm Signs Pro Baseball Rookie Phenom Bryce Harper As Sponsored Athlete
9. Masimo Signs Pronto-7™ Distribution Deal with Henry Schein
10. Unilife Signs Long-Term Supply Contract for the Unifill Prefilled Syringe
11. Wellness Center USA Inc. Signs Agreement to Acquire Psoria-Shield Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... BARBARA, Calif. , Dec. 23, 2014 In ... Junior Doctors, Association of Sierra Leone , ... Sierra Leone for the treatment of local health ... While a new dedicated Ebola care center was constructed ... virus, the facility is not available for local Sierra Leonean ...
(Date:12/22/2014)... MONMOUTH JUNCTION, N.J. , Dec. 22, 2014 ... immunotherapy company marketing its CytoSorb® blood purification technology ... cardiac surgery patients in 28 countries worldwide, today ... Di Russo , MD, FACS, as its Senior ... 2015. Dr. Di Russo ...
(Date:12/22/2014)... Research and Markets ( http://www.researchandmarkets.com/research/h3xm6q/us ) ... Blood Glucose Market" report to their offering. ... market insight focuses on the developments in the self-monitoring ... . Reimbursement analysis and the effects of competitive ... than 73 SMBG meters have been performed, based on ...
Breaking Medicine Technology:First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5US Self-monitoring Blood Glucose Market 2
... -- Global Information, Inc. (GII) is pleased to announce ... Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" by ... The Insulin Delivery Devices Market is Set to Grow ... 2017 GlobalData estimated the global insulin ...
... N.C., Jan. 13, 2012  Facing patent cliffs and shrinking ... either through in-licensing deals or M&A activities - as ... sound strategy, but a difficult one to effectively put ... a business is fraught with potential pitfalls. With 2012 ...
Cached Medicine Technology:Insulin Delivery Devices - Increasing Prevalence of Diabetes to Drive the Market 2Insulin Delivery Devices - Increasing Prevalence of Diabetes to Drive the Market 3Insulin Delivery Devices - Increasing Prevalence of Diabetes to Drive the Market 4Excellence Services Program Delivers a Road Map to Successfully Guide the Pharmaceutical Industry Through the New Alliance Landscape 2
(Date:12/24/2014)... December 24, 2014 Dr. Vu Ho, ... expansion of his practice and med-spa with the addition ... growing list of cosmetic treatments and services. , “Silk ... the skin,” says Dr. Ho. “As a result it ... as wrinkles, sun spots, discolorations or blemishes.” , Similar ...
(Date:12/24/2014)... 24, 2014 Mike Billings , ... with Derek Fenwick, PT, MBA, GCS, Director of ... stem from the passing of the Improving Medicare ... In this taping of the Infinicast, the two leaders ... the Social Security Act to standardize post-acute assessment data ...
(Date:12/24/2014)... -- A new, injectable weight-loss drug has been approved ... agency on Tuesday approved Saxenda (liraglutide) for adults who ... have at least one weight-related health condition, such as ... Patients taking the drug, made by Novo Nordisk, ... the FDA noted. "Obesity is a public health ...
(Date:12/24/2014)... HealthDay Reporter TUESDAY, Dec. 23, 2014 (HealthDay ... call for giving the cholesterol-lowering drugs known as statins to ... These new standards bring the association in line with the ... recommend giving low- or high-dose statins to all people at ... agree that the decision to start a statin should be ...
(Date:12/24/2014)... 2014 The 2014 Market Research ... and in-depth research report on COC industry. For ... information, including its definition, classification, application, industry chain ... This report also presents product specification, manufacturing process, ... by regions, technology and applications. Analysis also covers ...
Breaking Medicine News(10 mins):Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:FDA Approves New Weight-Loss Drug 2Health News:FDA Approves New Weight-Loss Drug 3Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 2Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 3Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 3
... study supports raising age for screening, which U.S. is pondering, ... adds evidence to support a growing movement to raise the ... detect cervical cancer. , In England, the recommended age at ... recently raised to 25. In the United States, however, ...
... Researchers have identified MEK4 as a pro-invasion protein and the ... according to a new study published online July 28 in ... Li Xu, M.D., Ph.D., and Raymond C. Bergan, M.D., of ... colleagues investigated the target for genistein in prostate cancer cells ...
... , , , , ... APFC ) today announced that it will release its ... Gibson, Chairman and Chief Executive Officer, invites you to participate in ... , The teleconference will be held Tuesday, August 4, 2009 ...
... , NEW YORK, July 28 Finding time to treat ... during stressful times. Here,s more on a how you can do ... Listen to this report from Kellogg,s at: , ... access video, audio, text, graphics and photos for free and unrestricted use ...
... , , , ... Eleven innovative veterinary students from around the world were ... animals and wildlife. The students, whose projects were funded through ... posters of their results at MAF,s annual meeting in June. ...
... , , BETHESDA, Md., July 28 Hanger ... of $193.5 million for the quarter ended June 30, 2009, an ... prior year. Net income increased $2.0 million, or 25.4%, to ... last year. Earnings per share for the second quarter of 2009 ...
Cached Medicine News:Health News:Teens May Not Benefit from Pap Tests 2Health News:Teens May Not Benefit from Pap Tests 3Health News:American Pacific to Release Financial Results and Hold Fiscal 2009 Third Quarter Investor Teleconference 2Health News:Eleven Veterinary Students Win Top Awards at Morris Animal Foundation's Annual Research Competition 2Health News:Eleven Veterinary Students Win Top Awards at Morris Animal Foundation's Annual Research Competition 3Health News:Eleven Veterinary Students Win Top Awards at Morris Animal Foundation's Annual Research Competition 4Health News:Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 2Health News:Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 3Health News:Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 4Health News:Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 5Health News:Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 6Health News:Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 7Health News:Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 8Health News:Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance 9
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: